Stay updated on P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.6.3 to v3.6.4, indicating a new content release.
    Difference
    0.1%
    Check dated 2026-07-28T10:30:51.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    New entries were added to the Study Record Dates for 2026-07-16, 2027-04-08, 2026-06-25, and 2026-06, and older dates 2025-07-20, 2026-05-04, 2025-07-09, and 2025-07 were removed. These changes update the historical timeline of the study record on the page.
    Difference
    0.3%
    Check dated 2026-07-21T11:14:46.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.2 to v3.6.3, indicating a small update to the page’s versioning or metadata rather than any changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-07T02:56:52.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a software update to the page rendering. This likely reflects backend/frontend improvements and does not modify the study information.
    Difference
    0.1%
    Check dated 2026-06-29T17:42:31.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment-status note have been added. The Intervention/Treatment label remains visible and the revision version updated to v3.6.0, reflecting a refresh of the study details and navigation.
    Difference
    0.5%
    Check dated 2026-06-15T08:20:45.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page shows an updated revision label from v3.5.4 to v3.5.5, reflecting a version update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-06-08T04:15:11.000Z thumbnail image

Stay in the know with updates to P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.